Mutations in methylenetetrahydrofolate reductase and in cysthationine beta synthase: Is there a link to homocysteine levels in peripheral arterial disease?

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3361-3366

  Santos, Maria E R C ^a   Das C L E Silva , Francisco ^a   Gomes, Karina B ^b   Fernandes, Ana Paula M ^b   Freitas, Fernanda R ^b   Faria, Mayara C ^b   Mota, Ana Paula L ^b   Carvalho, Maria G ^b  

^a Nucleo de Pos graduacao Santa Casa   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cystathionine beta synthase; Homocysteine; Methylenetetrahydrofolate reductase; Peripheral arterial disease

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME METABOLISM; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

AGED; BRAZIL; CYSTATHIONINE BETA-SYNTHASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS;

EID: 80052500324     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0443-1     Document Type: Article

References (29)

1. Hiatt WR, Hoag S, Hamman RF (1995) Effect of diagnostic criteria on the prevalence of peripheral arterial disease: the San Luis Valley diabetes study. Circulation 91:1472-1479
2. Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR et al (2001) Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345:1593-1600 (Pubitemid 33126838)
3. Pasternak RC, Criqui MH, Benjamin EJ, Fowkes FG, Isselbacher EM, McCullough PA et al (2004) Atherosclerotic vascular disease conference: writing group I: epidemiology. Circulation 109:2605-2612 (Pubitemid 38720564)
4. TransAtlantic Inter-Society Consensus (TASC) (2000) Management of peripheral vascular disease. Int Angiol 19(Suppl 1):15-28
5. Bordeaux LM, Reich LM, Hirsch AT (2003) The epidemiology and natural history of peripheral arterial disease. In: Coffman JD, Eberhardt RT (eds) Peripheral arterial disease diagnosis and treatment. Humana press, New Jersey, pp 21-34
6. Cardwell S, McCarthy M, Martin SC (1998) Hyperhomocysteinaemia, peripheral vascular disease and neointimal hyperplasia in elderly patients. Br J Surg 85:685-715
7. Boers GH, Smals Ag, Trijbels FJ, Fowler B, Bakkeren JA, Schoonderwaldt HC et al (1985) Heterozygosite for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 313:709-715 (Pubitemid 15232423)
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al (1991) Hyperhomocystinaemia: an independent risk factor for vascular disease. N Engl J Med 324:1149-1155
9. Asfar S, Safar H (2007) Homocysteine levels and peripheral arterial occlusive disease: a prospective cohort study and review of the literature. J Cardiovasc Surg 48:601-605 (Pubitemid 350104070)
10. Garofolo L, Barros N Jr, Miranda F Jr, D'Almeida V, Cardien LC, Ferreira SR (2007) Association of increased levels of homocysteine and peripheral arterial disease in a Japanese-Brazilian population. Eur J Vasc Endovasc Surg 34:23-28 (Pubitemid 46852385)
11. Malinow MR, Kang SS, Taylor L, Wong PW, Coull B, Inahara T et al (1989) Prevalence of hyperhomocysteinemia in patients with peripheral arterial disease. Circulation 79:1180-1188 (Pubitemid 19155752)
12. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B et al (1990) Impaired homocysteine metabolism in early onset cerebral and peripheral occlusive disease. Atherosclerosis 81:51-60
13. Taylor LM, Defrang RD, Harris EJ, Porter JM (1991) The association of elevated plasma homocysteine with progression of symptomatic peripheral arterial disease. J Vasc Surg 13:128-136
14. Bhargava S, Parakh R, Manocha A, Ali A, Srivastava L (2007) Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease. Vascular 15:149-153 (Pubitemid 47280659)
15. Carmody BJ, Arora S, Avena R, Cosby K, Sidawy AN (1999) Folic acid intake at levels available in dietary supplements may prove protective in hyperhomocysteinemia induced atherosclerosis. J Vasc Surg 30:1121-1128
16. Pyeritz RE (2000) Hereditary risk factors for atherosclerotic occlusive disease. J Vasc Surg 31:1279-1280
17. Pereira AC, Schettert IT, Morandini Filho AA, Guerra-Shinohara EM, Krieger JE (2004) Methylenetetrahydrofolate reductase (MTHFR) C677T gene variant modulates the homocysteine folate correlation in a mild folate-deficient population. Clin Chim Acta 340:99-105 (Pubitemid 38167513)
18. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217-246 (Pubitemid 29380603)
19. Castro R, Rivera I, Ravasco P, Camilo ME, Jakobs C, Blom HJ et al (2003) 5, 10-Methylenotetrahydrofolate reductase 677C-T and 1298 A-C mutations are genetic determinants of elevated homocysteine. QLM 96:297-303 (Pubitemid 36432389)
20. Aléssio A, Siqueira L, Bydlowski S, Höehr N, Annichino-Bizzacchi J (2008) Polymorphisms in the CBS gene and homocysteine, folate and vitamin B12 levels: association with polymorphisms in the MTHFR and MTRR genes in Brazilian children. Am J Med Genet A146A:2598-2602
21. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG et al (1995) A candidate genetic risk factor for vascular disease: a commom mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
22. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:12002
23. Guerzoni A, Pavarino-Bertelli E, Godoy M, Graça C, Biselli P, Souza D, Bertollo E (2007) Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease. Sao Paulo Med J 125:4-8 (Pubitemid 46813340)
24. Aras O, Hanson N, Yang F, Tsai M (2000) Influence of 699C→T and 1080C→T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels. Clin Genet 58:455-945
25. Franco R, Maffei F, Lourenço D, Piccinato C, Morelli V, Thomazini I et al (1998) The frequency of 844ins68 mutation in the cystathionine beta-synthase gene is not increased in patients with venous thrombosis. Haematologica 83:1006-1008 (Pubitemid 29039471)
26. Frosst P, Blom H, Milos R, Goyette P, Shepparó A, Matthews R (1995) A candidate genetic risck factor for vascular disease: a commom mutation in methylenetetrahydrofolate reductase. Nat Genet 10:11-113
27. Dutta S, Sinha S, Chatoopadhyway A, Gangopadhyay PK, Mukhopadhyay J, Singh M et al (2005) Cystathionine β-synthase T833C/844INS68 polymorphism: a family-based study on mentally retarded children. Behav Brain Funct 26:1-25
28. Jhee KH, Kruger WD (2005) The role of cystathionine betasynthase in homocysteine metabolism. Antioxid Redox Signal 7:813-822 (Pubitemid 40563223)
29. Den Heijer M, Lewington S, Clarke R (2005) Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 3:292-299 (Pubitemid 41623617)